63 related articles for article (PubMed ID: 25015289)
1. Proteomic analysis reveals a FANCA-modulated neddylation pathway involved in CXCR5 membrane targeting and cell mobility.
Renaudin X; Guervilly JH; Aoufouchi S; Rosselli F
J Cell Sci; 2014 Aug; 127(Pt 16):3546-54. PubMed ID: 25015289
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic FANCA-FANCC complex interacts and stabilizes the cytoplasm-dislocalized leukemic nucleophosmin protein (NPMc).
Du W; Li J; Sipple J; Chen J; Pang Q
J Biol Chem; 2010 Nov; 285(48):37436-44. PubMed ID: 20864535
[TBL] [Abstract][Full Text] [Related]
3. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of matrix metalloproteinases, invasion and growth of Fanconi anemia human FANCA and FANCC lymphoblasts by nutrient mixture.
Roomi MW; Bhanap B; Roomi NW; Niedzwiecki A; Rath M
Exp Oncol; 2014 Sep; 36(3):212-4. PubMed ID: 25265357
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
Huber PA; Medhurst AL; Youssoufian H; Mathew CG
Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
[TBL] [Abstract][Full Text] [Related]
6. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
Kachnic LA; Li L; Fournier L; Willers H
Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
[TBL] [Abstract][Full Text] [Related]
7. Fanconi anemia A protein participates in nucleolar homeostasis maintenance and ribosome biogenesis.
Gueiderikh A; Maczkowiak-Chartois F; Rouvet G; Souquère-Besse S; Apcher S; Diaz JJ; Rosselli F
Sci Adv; 2021 Jan; 7(1):. PubMed ID: 33523834
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Fanconi anaemia genes FANCA, FANCC and FANCL in cervical cancer susceptibility.
Juko-Pecirep I; Ivansson EL; Gyllensten UB
Gynecol Oncol; 2011 Aug; 122(2):377-81. PubMed ID: 21543111
[TBL] [Abstract][Full Text] [Related]
10. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
12. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
14. Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export.
Ferrer M; Rodríguez JA; Spierings EA; de Winter JP; Giaccone G; Kruyt FA
Hum Mol Genet; 2005 May; 14(10):1271-81. PubMed ID: 15790592
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.
Levran O; Diotti R; Pujara K; Batish SD; Hanenberg H; Auerbach AD
Hum Mutat; 2005 Feb; 25(2):142-9. PubMed ID: 15643609
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of Fanconi anaemia--an old problem, a new insight.
Ahmad SI; Hanaoka F; Kirk SH
Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anaemia proteins: major roles in cell protection against oxidative damage.
Pagano G; Youssoufian H
Bioessays; 2003 Jun; 25(6):589-95. PubMed ID: 12766948
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
20. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
Chen F; Zhang KJ; Zuo XL; Zeng XC
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
